We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
This chapter highlights the clinical, pathophysiologic, and biochemical links between inflammatory bowel disease (IBD) and ischemic stroke. Deep venous thrombosis (DVT) and pulmonary embolism (PE) account for the overwhelming majority of thrombotic events in patients with IBD. Descriptions of IBD-associated central nervous system (CNS) vasculitis are based on angiography showing segmental narrowing in the small to medium-sized arteries. Of the many IBD-related hypercoagulable state manifestations, an estimated 10 percentage are ischemic strokes. Hyperhomocysteinemia has recently emerged as an independent risk factor for stroke; homocysteine is a sulfur-containing amino acid formed during the demethylation of the amino acid methionine. The mechanism for ischemic strokes in IBD patients is multifactorial, but likely secondary to an abnormal coagulability profile and, in rare situations, cerebral vasculitis. Better management of IBD flares, improved compliance with newer IBD medications, and quicker surgical interventions might lead to better outcomes and stroke risk reduction.
Ischemic cerebrovascular disease accounts for more than 85% of all clinical stroke events with the remainder divided approximately equally between intracerebral hemorrhage (ICH) and subarachnoid hemorrhage (SH). The diagnosis of stroke requires differentiation from other diseases of the brain of acute onset based on clinical history, neurologic exam, and brain imaging. At least two-thirds of ischemic strokes result from atherothrombotic occlusive disease while embolism from a documented cardiac source and infarction of undetermined cause constitute the balance. Strokes resulting from hemorrhage, intraparenchymatous and subarachnoid, are fatal in about half the cases and hemorrhage survivors often have severe permanent disability. A number of key risk factors for stroke have been identified and their impact estimated. Hypertension is the principal risk factor for ischemic stroke with risk rising in proportion to level of blood pressure, systolic as well as diastolic.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.